Updates and news related to prostate cancer:
New Prognostic Tool for Prostate Cancer
LuPSMA offers a new option for men with castration-resistant PSMA-positive metastatic cancer.
PSMA-PET/CT and Prostate Cancer
Detection may be more accurately than mpMRI
Research Finds Monitoring Better Than Active Treatment for Low-Risk Prostate Cancer
Men with low-risk prostate cancer on active surveillance report fewer problems with sexual function than those on other treatments.
Lutetium PSMA, Molecular Imaging in Prostate Cancer
Molecular imaging tools have the potential to transform how we diagnose and treat men with prostate cancer.
Adjuvant Likely Bests Salvage Radiation in High-Risk Prostate Cancer
Study will likely change the standard of care
Challenges of Using MRI When Diagnosing Prostate Cancer
A discussion on the challenges associated with the use of MRI to diagnose prostate cancer including insurance coverage and patient discomfort
Managing Prostate Cancer Treatment Side Effects
Early management of side effects has been shown to help patients live longer, better lives.
Adjuvant Radiation Therapy
This therapy may yield a significant reduction in all-cause mortality in high-risk prostate cancer vs salvage
‘New Paradigm’ for Screening?
Blood test shows accuracy for early cancer detection
Metformin Possibly Beneficial in Advanced Prostate Cancer
Metformin plus standard of care (SOC) prolonged castration-resistant prostate cancer-free survival compared with SOC alone in patients with low-tumor-volume metastatic hormone-sensitive prostate cancer and high-risk locally advanced disease.